Literature DB >> 18677500

Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.

B Chigbu1, S Onwere, C Kamanu, C Aluka, O Okoro, P Feyi-Waboso, C Onichakwe.   

Abstract

OBJECTIVE: We compared the outcomes of bloodless emergency laparotomies for uterine rupture in twenty Jehovah's Witness (JW) women who were in a state of haemorrhagic shock with 45 other women who received blood transfusion.
METHODS: The case records of twenty Jehovah's Witness patients, who underwent bloodless emergency laparotomies for ruptured uterus complicated by haemorrhagic shock between 1 January 2000 and 31 December 2006 were reviewed. We also reviewed the case records of 45 other patients who underwent similar surgical procedures for similar indications and in whom blood was transfused. The outcome variables compared were maternal deaths, infectious morbidity, acute respiratory distress syndrome, disseminated intravascular coagulation, length of post laparotomy ventilatory support, and length of postpartum hospitalization.
RESULTS: Demographic and obstetric characteristics were similar in both groups. Seventeen out of the twenty Jehovah's Witness patients who refused blood transfusion survived the laparotomies and were discharged home in good condition. Three died of peritonitis. Six out of the 45 patients who received blood transfusion also died of peritonitis and one died of disseminated intravascular coagulopathy. The average duration of post partum hospitalization was 8 days in the group of patients transfused and 7 days in the group not transfused. Disseminated intravascular coagulation occurred post partum in two of the patients transfused. No case of acute respiratory distress syndrome or amniotic fluid embolism was identified in either group.
CONCLUSION: Patients who are in haemorrhagic shock from ruptured uterus and refuse blood transfusion can still be salvaged in a low resource setting. The study adds evidence that major operative procedures can be carried out on Jehovah's Witness patients without blood transfusions or blood products.

Entities:  

Mesh:

Year:  2008        PMID: 18677500     DOI: 10.1007/s00404-008-0748-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Successful bowel surgery at hemoglobin 2 g/dL without blood transfusion.

Authors:  Ramakrishnapillai Padmakumar; Madhukara Pai; Shams Farish; Jayadevan Rajeev; Thampi Sanjeev; Thekke Veetil Sreevalsan; Binu Sheetal; Yesudas Santhakumari Sooraj; Shamna Safar Rowther
Journal:  World J Gastrointest Surg       Date:  2013-08-27

2.  Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases.

Authors:  Sung Yong Oh; Sung-Hyun Kim; Hyuk-Chan Kwon; Suee Lee; Kyeong Hee Kim; Kyung A Kwon; Jong-Hwan Lee; Kyu-Yeol Lee; Hyo-Jin Kim
Journal:  Support Care Cancer       Date:  2009-10-20       Impact factor: 3.603

Review 3.  Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.

Authors:  Iftach Sagy; Alan Jotkowitz; Leonid Barski
Journal:  J Relig Health       Date:  2017-04

4.  Comparison of safety and efficacy between laparoscopic myomectomy and traditional laparotomy for patients with uterine fibroids and their effect on pregnancy rate after surgery.

Authors:  Xueqiao Kan; Xiaoxia Shen; Li Feng; Yuqing Hu; Jiadong Yu; Xiaoju Yang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 5.  Patient blood management - a new paradigm for transfusion medicine?

Authors:  A Thomson; S Farmer; A Hofmann; J Isbister; A Shander
Journal:  ISBT Sci Ser       Date:  2009-10-14

6.  Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions.

Authors:  Dante Mário Langhi; Dimas Tadeu Covas; Jose Francisco Comenalli Marques; Alfredo Mendrone; Eugênia Maria Amorim Ubiali; Gil Cunha De Santis; Gizela Kelmann; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.